Advanced search options

Advanced Search Options 🞨

Browse by author name (“Author name starts with…”).

Find ETDs with:

in
/  
in
/  
in
/  
in

Written in Published in Earliest date Latest date

Sorted by

Results per page:

Sorted by: relevance · author · university · dateNew search

You searched for subject:(LRG 1 glycosylation urinary biomarker inflammation PD L1 reporter luciferase assay cancer immunotherapy). Showing records 1 – 30 of 62780 total matches.

[1] [2] [3] [4] [5] … [2093]

Search Limiters

Last 2 Years | English Only

Degrees

Levels

Languages

Country

▼ Search Limiters


Cleveland State University

1. Zheng, Qiaoyun. Study of Cancer Related Proteins: LRG-1 and PD-L1.

Degree: PhD, College of Sciences and Health Professions, 2017, Cleveland State University

 PROJECT I:In this study, we used the proteomic method to identify a potent biomarker candidate as leucine-rich-a-2-glycoprotein-1 (LRG-1) for cancer from the urine of patients… (more)

Subjects/Keywords: Biomedical Research; Health Sciences; Pharmacy Sciences; Molecular Biology; LRG-1, glycosylation, urinary biomarker, inflammation, PD-L1, reporter luciferase assay, cancer, immunotherapy

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Zheng, Q. (2017). Study of Cancer Related Proteins: LRG-1 and PD-L1. (Doctoral Dissertation). Cleveland State University. Retrieved from http://rave.ohiolink.edu/etdc/view?acc_num=csu1495735827467521

Chicago Manual of Style (16th Edition):

Zheng, Qiaoyun. “Study of Cancer Related Proteins: LRG-1 and PD-L1.” 2017. Doctoral Dissertation, Cleveland State University. Accessed December 09, 2019. http://rave.ohiolink.edu/etdc/view?acc_num=csu1495735827467521.

MLA Handbook (7th Edition):

Zheng, Qiaoyun. “Study of Cancer Related Proteins: LRG-1 and PD-L1.” 2017. Web. 09 Dec 2019.

Vancouver:

Zheng Q. Study of Cancer Related Proteins: LRG-1 and PD-L1. [Internet] [Doctoral dissertation]. Cleveland State University; 2017. [cited 2019 Dec 09]. Available from: http://rave.ohiolink.edu/etdc/view?acc_num=csu1495735827467521.

Council of Science Editors:

Zheng Q. Study of Cancer Related Proteins: LRG-1 and PD-L1. [Doctoral Dissertation]. Cleveland State University; 2017. Available from: http://rave.ohiolink.edu/etdc/view?acc_num=csu1495735827467521


East Carolina University

2. Atwell, Druid Carlisle. Identification of Biomarkers in Non-Small Cell Lung Cancer Patients Treated with PD-1 Monoclonal Antibody Immunotherapy.

Degree: 2018, East Carolina University

Cancer immunotherapy works by taking a patient’s existing immune system and priming it to recognize cancer cells in order for immune cells to mount an… (more)

Subjects/Keywords: Cancer; Immunotherapy; PD-1; PD-L1; Immune System

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Atwell, D. C. (2018). Identification of Biomarkers in Non-Small Cell Lung Cancer Patients Treated with PD-1 Monoclonal Antibody Immunotherapy. (Thesis). East Carolina University. Retrieved from http://hdl.handle.net/10342/7016

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Atwell, Druid Carlisle. “Identification of Biomarkers in Non-Small Cell Lung Cancer Patients Treated with PD-1 Monoclonal Antibody Immunotherapy.” 2018. Thesis, East Carolina University. Accessed December 09, 2019. http://hdl.handle.net/10342/7016.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Atwell, Druid Carlisle. “Identification of Biomarkers in Non-Small Cell Lung Cancer Patients Treated with PD-1 Monoclonal Antibody Immunotherapy.” 2018. Web. 09 Dec 2019.

Vancouver:

Atwell DC. Identification of Biomarkers in Non-Small Cell Lung Cancer Patients Treated with PD-1 Monoclonal Antibody Immunotherapy. [Internet] [Thesis]. East Carolina University; 2018. [cited 2019 Dec 09]. Available from: http://hdl.handle.net/10342/7016.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Atwell DC. Identification of Biomarkers in Non-Small Cell Lung Cancer Patients Treated with PD-1 Monoclonal Antibody Immunotherapy. [Thesis]. East Carolina University; 2018. Available from: http://hdl.handle.net/10342/7016

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

3. Yazbeck, Nathalie. Contrôle de l’immunité antitumorale par la signalisation de SQSTM1 : Control of antitumor immunity by the SQSTM1 dependent signaling.

Degree: Docteur es, Interractions moléculaires et cellulaires, 2018, Côte d'Azur

La dernière décennie a connu une révolution dans le traitement du cancer en s'éloignant des médicaments conventionnels qui ciblent directement la tumeur (comme les chimiothérapies… (more)

Subjects/Keywords: Immunothérapies; PD1/PD‐L1; Biomarqueurs; Sequestosome 1; Immunotherapies; PD1/PD‐L1; Biomarker; Sequestosome 1

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Yazbeck, N. (2018). Contrôle de l’immunité antitumorale par la signalisation de SQSTM1 : Control of antitumor immunity by the SQSTM1 dependent signaling. (Doctoral Dissertation). Côte d'Azur. Retrieved from http://www.theses.fr/2018AZUR4072

Chicago Manual of Style (16th Edition):

Yazbeck, Nathalie. “Contrôle de l’immunité antitumorale par la signalisation de SQSTM1 : Control of antitumor immunity by the SQSTM1 dependent signaling.” 2018. Doctoral Dissertation, Côte d'Azur. Accessed December 09, 2019. http://www.theses.fr/2018AZUR4072.

MLA Handbook (7th Edition):

Yazbeck, Nathalie. “Contrôle de l’immunité antitumorale par la signalisation de SQSTM1 : Control of antitumor immunity by the SQSTM1 dependent signaling.” 2018. Web. 09 Dec 2019.

Vancouver:

Yazbeck N. Contrôle de l’immunité antitumorale par la signalisation de SQSTM1 : Control of antitumor immunity by the SQSTM1 dependent signaling. [Internet] [Doctoral dissertation]. Côte d'Azur; 2018. [cited 2019 Dec 09]. Available from: http://www.theses.fr/2018AZUR4072.

Council of Science Editors:

Yazbeck N. Contrôle de l’immunité antitumorale par la signalisation de SQSTM1 : Control of antitumor immunity by the SQSTM1 dependent signaling. [Doctoral Dissertation]. Côte d'Azur; 2018. Available from: http://www.theses.fr/2018AZUR4072


George Mason University

4. Dey, Douglass. Investigation of Small Peptide Inhibitors on PD-1 PD-L1 Protein-Protein Interactions .

Degree: George Mason University

Cancer is a complex disease in which abnormal cells divide uncontrollably and invade body tissues, leading to eventual organ failure and death. These abnormal cells… (more)

Subjects/Keywords: PD-1; PD-L1; small peptide inhibitors; checkpoint inhibition; immune checkpoints; cancer immunotherapy

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Dey, D. (n.d.). Investigation of Small Peptide Inhibitors on PD-1 PD-L1 Protein-Protein Interactions . (Thesis). George Mason University. Retrieved from http://hdl.handle.net/1920/11121

Note: this citation may be lacking information needed for this citation format:
No year of publication.
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Dey, Douglass. “Investigation of Small Peptide Inhibitors on PD-1 PD-L1 Protein-Protein Interactions .” Thesis, George Mason University. Accessed December 09, 2019. http://hdl.handle.net/1920/11121.

Note: this citation may be lacking information needed for this citation format:
No year of publication.
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Dey, Douglass. “Investigation of Small Peptide Inhibitors on PD-1 PD-L1 Protein-Protein Interactions .” Web. 09 Dec 2019.

Note: this citation may be lacking information needed for this citation format:
No year of publication.

Vancouver:

Dey D. Investigation of Small Peptide Inhibitors on PD-1 PD-L1 Protein-Protein Interactions . [Internet] [Thesis]. George Mason University; [cited 2019 Dec 09]. Available from: http://hdl.handle.net/1920/11121.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation
No year of publication.

Council of Science Editors:

Dey D. Investigation of Small Peptide Inhibitors on PD-1 PD-L1 Protein-Protein Interactions . [Thesis]. George Mason University; Available from: http://hdl.handle.net/1920/11121

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation
No year of publication.


Queens University

5. Black, Madison. The PD-1/PD-L1 Axis: An Immune-Mediated Mechanism of Chemoresistance in Cancer .

Degree: Anatomy and Cell Biology, 2015, Queens University

 The ability of tumour cells to avoid immune destruction (immune escape) and their acquired resistance to anti-cancer drugs constitute important barriers to the successful management… (more)

Subjects/Keywords: Chemoresistance; PD-1/PD-L1

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Black, M. (2015). The PD-1/PD-L1 Axis: An Immune-Mediated Mechanism of Chemoresistance in Cancer . (Thesis). Queens University. Retrieved from http://hdl.handle.net/1974/13145

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Black, Madison. “The PD-1/PD-L1 Axis: An Immune-Mediated Mechanism of Chemoresistance in Cancer .” 2015. Thesis, Queens University. Accessed December 09, 2019. http://hdl.handle.net/1974/13145.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Black, Madison. “The PD-1/PD-L1 Axis: An Immune-Mediated Mechanism of Chemoresistance in Cancer .” 2015. Web. 09 Dec 2019.

Vancouver:

Black M. The PD-1/PD-L1 Axis: An Immune-Mediated Mechanism of Chemoresistance in Cancer . [Internet] [Thesis]. Queens University; 2015. [cited 2019 Dec 09]. Available from: http://hdl.handle.net/1974/13145.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Black M. The PD-1/PD-L1 Axis: An Immune-Mediated Mechanism of Chemoresistance in Cancer . [Thesis]. Queens University; 2015. Available from: http://hdl.handle.net/1974/13145

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

6. Simard, François. Implication of immune system in chondrosarcoma progression and therapeutic response : Could immunotherapy play a role in chondrosarcoma treatment ? : L’implication du système immunitaire dans la progression et la réponse thérapeutique du chondrosarcome : Est-ce que l’immunothérapie peut jouer un rôle dans le traitement du chondrosarcome ?.

Degree: Docteur es, Biologie, 2016, Lyon

Le chondrosarcome (CHS) est caractérisé par une grande chimio et radiorésistance ; il y a un besoin urgent de nouvelles stratégies thérapeutiques pour cette tumeur.… (more)

Subjects/Keywords: Chondrosarcome; Lymphocyte; PD-1; PD-L1; Macrophage; Immunothérapie; PI3K/Akt/mTOR; Immunosurveillance; Chondrosarcoma; Lymphocyte; PD-1; PD-L1; Macrophages; Immunotherapy; PI3K/Akt/mTOR; Immunosurveillance; 571.96

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Simard, F. (2016). Implication of immune system in chondrosarcoma progression and therapeutic response : Could immunotherapy play a role in chondrosarcoma treatment ? : L’implication du système immunitaire dans la progression et la réponse thérapeutique du chondrosarcome : Est-ce que l’immunothérapie peut jouer un rôle dans le traitement du chondrosarcome ?. (Doctoral Dissertation). Lyon. Retrieved from http://www.theses.fr/2016LYSE1073

Chicago Manual of Style (16th Edition):

Simard, François. “Implication of immune system in chondrosarcoma progression and therapeutic response : Could immunotherapy play a role in chondrosarcoma treatment ? : L’implication du système immunitaire dans la progression et la réponse thérapeutique du chondrosarcome : Est-ce que l’immunothérapie peut jouer un rôle dans le traitement du chondrosarcome ?.” 2016. Doctoral Dissertation, Lyon. Accessed December 09, 2019. http://www.theses.fr/2016LYSE1073.

MLA Handbook (7th Edition):

Simard, François. “Implication of immune system in chondrosarcoma progression and therapeutic response : Could immunotherapy play a role in chondrosarcoma treatment ? : L’implication du système immunitaire dans la progression et la réponse thérapeutique du chondrosarcome : Est-ce que l’immunothérapie peut jouer un rôle dans le traitement du chondrosarcome ?.” 2016. Web. 09 Dec 2019.

Vancouver:

Simard F. Implication of immune system in chondrosarcoma progression and therapeutic response : Could immunotherapy play a role in chondrosarcoma treatment ? : L’implication du système immunitaire dans la progression et la réponse thérapeutique du chondrosarcome : Est-ce que l’immunothérapie peut jouer un rôle dans le traitement du chondrosarcome ?. [Internet] [Doctoral dissertation]. Lyon; 2016. [cited 2019 Dec 09]. Available from: http://www.theses.fr/2016LYSE1073.

Council of Science Editors:

Simard F. Implication of immune system in chondrosarcoma progression and therapeutic response : Could immunotherapy play a role in chondrosarcoma treatment ? : L’implication du système immunitaire dans la progression et la réponse thérapeutique du chondrosarcome : Est-ce que l’immunothérapie peut jouer un rôle dans le traitement du chondrosarcome ?. [Doctoral Dissertation]. Lyon; 2016. Available from: http://www.theses.fr/2016LYSE1073

7. Kostine, Marie. Defining the immune microenvironment in sarcoma : could immunotherapy be part of the treatment strategy in sarcoma patients ? : Etude du microenvironnement immunitaire dans les sarcomes : pourrait-il y avoir une place pour l'immunothérapie dans la stratégie thérapeutique ?.

Degree: Docteur es, Biologie Cellulaire et Physiopathologie, 2018, Bordeaux

La chirurgie est la pierre angulaire du traitement curatif des sarcomes, lorsqu’elle est possible. En revanche, en cas de maladie avancée ou métastatique, les traitements… (more)

Subjects/Keywords: Sarcome; Immunothérapie; Pd-1/pd-L1; Hla; Macrophages associés aux tumeurs; Lymphocytes T; Sarcoma; Immunotherapy; Pd-1/pd-L1; Hla; Tumor-Associated macrophages; T cells

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Kostine, M. (2018). Defining the immune microenvironment in sarcoma : could immunotherapy be part of the treatment strategy in sarcoma patients ? : Etude du microenvironnement immunitaire dans les sarcomes : pourrait-il y avoir une place pour l'immunothérapie dans la stratégie thérapeutique ?. (Doctoral Dissertation). Bordeaux. Retrieved from http://www.theses.fr/2018BORD0387

Chicago Manual of Style (16th Edition):

Kostine, Marie. “Defining the immune microenvironment in sarcoma : could immunotherapy be part of the treatment strategy in sarcoma patients ? : Etude du microenvironnement immunitaire dans les sarcomes : pourrait-il y avoir une place pour l'immunothérapie dans la stratégie thérapeutique ?.” 2018. Doctoral Dissertation, Bordeaux. Accessed December 09, 2019. http://www.theses.fr/2018BORD0387.

MLA Handbook (7th Edition):

Kostine, Marie. “Defining the immune microenvironment in sarcoma : could immunotherapy be part of the treatment strategy in sarcoma patients ? : Etude du microenvironnement immunitaire dans les sarcomes : pourrait-il y avoir une place pour l'immunothérapie dans la stratégie thérapeutique ?.” 2018. Web. 09 Dec 2019.

Vancouver:

Kostine M. Defining the immune microenvironment in sarcoma : could immunotherapy be part of the treatment strategy in sarcoma patients ? : Etude du microenvironnement immunitaire dans les sarcomes : pourrait-il y avoir une place pour l'immunothérapie dans la stratégie thérapeutique ?. [Internet] [Doctoral dissertation]. Bordeaux; 2018. [cited 2019 Dec 09]. Available from: http://www.theses.fr/2018BORD0387.

Council of Science Editors:

Kostine M. Defining the immune microenvironment in sarcoma : could immunotherapy be part of the treatment strategy in sarcoma patients ? : Etude du microenvironnement immunitaire dans les sarcomes : pourrait-il y avoir une place pour l'immunothérapie dans la stratégie thérapeutique ?. [Doctoral Dissertation]. Bordeaux; 2018. Available from: http://www.theses.fr/2018BORD0387


Texas Medical Center

8. Aquino Lopez, Arianexys; and#60;pand#62;0000-0001-5515-6510and#60;/pand#62. DYNAMIC ASSESSMENT OF NK CELL INTERACTIONS WITH PEDIATRIC TUMOR CELLS TO PREDICT RESPONSE TO IMMUNOTHERAPY.

Degree: PhD, 2017, Texas Medical Center

  Due to Natural Killer (NK) cells’ capacity to target tumor cells without prior sensitization, adoptive NK cell therapy represents a promising immunotherapy approach for… (more)

Subjects/Keywords: NK cells; IFN gamma; ICAM-1; MHC; PD-L1; CyTOF; mass cytometry; pediatric cancer; immunotherapy; Hematology; Immunology and Infectious Disease; Medical Immunology; Medicine and Health Sciences; Neoplasms; Oncology; Pediatrics

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Aquino Lopez, A. a. (2017). DYNAMIC ASSESSMENT OF NK CELL INTERACTIONS WITH PEDIATRIC TUMOR CELLS TO PREDICT RESPONSE TO IMMUNOTHERAPY. (Doctoral Dissertation). Texas Medical Center. Retrieved from http://digitalcommons.library.tmc.edu/utgsbs_dissertations/821

Chicago Manual of Style (16th Edition):

Aquino Lopez, Arianexys; and#60;pand#62;0000-0001-5515-6510and#60;/pand#62. “DYNAMIC ASSESSMENT OF NK CELL INTERACTIONS WITH PEDIATRIC TUMOR CELLS TO PREDICT RESPONSE TO IMMUNOTHERAPY.” 2017. Doctoral Dissertation, Texas Medical Center. Accessed December 09, 2019. http://digitalcommons.library.tmc.edu/utgsbs_dissertations/821.

MLA Handbook (7th Edition):

Aquino Lopez, Arianexys; and#60;pand#62;0000-0001-5515-6510and#60;/pand#62. “DYNAMIC ASSESSMENT OF NK CELL INTERACTIONS WITH PEDIATRIC TUMOR CELLS TO PREDICT RESPONSE TO IMMUNOTHERAPY.” 2017. Web. 09 Dec 2019.

Vancouver:

Aquino Lopez Aa. DYNAMIC ASSESSMENT OF NK CELL INTERACTIONS WITH PEDIATRIC TUMOR CELLS TO PREDICT RESPONSE TO IMMUNOTHERAPY. [Internet] [Doctoral dissertation]. Texas Medical Center; 2017. [cited 2019 Dec 09]. Available from: http://digitalcommons.library.tmc.edu/utgsbs_dissertations/821.

Council of Science Editors:

Aquino Lopez Aa. DYNAMIC ASSESSMENT OF NK CELL INTERACTIONS WITH PEDIATRIC TUMOR CELLS TO PREDICT RESPONSE TO IMMUNOTHERAPY. [Doctoral Dissertation]. Texas Medical Center; 2017. Available from: http://digitalcommons.library.tmc.edu/utgsbs_dissertations/821


Vanderbilt University

9. Perry, Evan Thomas. Discovery of small molecule inhibitors of immune checkpoint proteins.

Degree: PhD, Biochemistry, 2019, Vanderbilt University

 CTLA-4 and PD-1 are immune checkpoints that inhibit T cell activity to maintain immune homeostasis. These checkpoints have also emerged as highly validated cancer targets… (more)

Subjects/Keywords: fragment-based drug discovery; cancer drug discovery; immunotherapy; structure-based design; PD-L1 inhibitor

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Perry, E. T. (2019). Discovery of small molecule inhibitors of immune checkpoint proteins. (Doctoral Dissertation). Vanderbilt University. Retrieved from http://etd.library.vanderbilt.edu/available/etd-03152019-112318/ ;

Chicago Manual of Style (16th Edition):

Perry, Evan Thomas. “Discovery of small molecule inhibitors of immune checkpoint proteins.” 2019. Doctoral Dissertation, Vanderbilt University. Accessed December 09, 2019. http://etd.library.vanderbilt.edu/available/etd-03152019-112318/ ;.

MLA Handbook (7th Edition):

Perry, Evan Thomas. “Discovery of small molecule inhibitors of immune checkpoint proteins.” 2019. Web. 09 Dec 2019.

Vancouver:

Perry ET. Discovery of small molecule inhibitors of immune checkpoint proteins. [Internet] [Doctoral dissertation]. Vanderbilt University; 2019. [cited 2019 Dec 09]. Available from: http://etd.library.vanderbilt.edu/available/etd-03152019-112318/ ;.

Council of Science Editors:

Perry ET. Discovery of small molecule inhibitors of immune checkpoint proteins. [Doctoral Dissertation]. Vanderbilt University; 2019. Available from: http://etd.library.vanderbilt.edu/available/etd-03152019-112318/ ;


Texas Medical Center

10. Bartkowiak, Todd. Novel Imaging-Based Techniques Reveal a Role for PD-1/PD-L1 in Tumor Immune Surveillance in the Lung.

Degree: MS, 2013, Texas Medical Center

  The binding of immune inhibitory receptor Programmed Death 1 (PD-1) on T cells to its ligand PD-L1 has been implicated as a major contributor… (more)

Subjects/Keywords: PD-1; PD-L1; Intravital microscopy; Tumor immune surveillance; Immunotherapy; Immunoprophylaxis and Therapy; Investigative Techniques; Medicine and Health Sciences

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Bartkowiak, T. (2013). Novel Imaging-Based Techniques Reveal a Role for PD-1/PD-L1 in Tumor Immune Surveillance in the Lung. (Masters Thesis). Texas Medical Center. Retrieved from http://digitalcommons.library.tmc.edu/utgsbs_dissertations/354

Chicago Manual of Style (16th Edition):

Bartkowiak, Todd. “Novel Imaging-Based Techniques Reveal a Role for PD-1/PD-L1 in Tumor Immune Surveillance in the Lung.” 2013. Masters Thesis, Texas Medical Center. Accessed December 09, 2019. http://digitalcommons.library.tmc.edu/utgsbs_dissertations/354.

MLA Handbook (7th Edition):

Bartkowiak, Todd. “Novel Imaging-Based Techniques Reveal a Role for PD-1/PD-L1 in Tumor Immune Surveillance in the Lung.” 2013. Web. 09 Dec 2019.

Vancouver:

Bartkowiak T. Novel Imaging-Based Techniques Reveal a Role for PD-1/PD-L1 in Tumor Immune Surveillance in the Lung. [Internet] [Masters thesis]. Texas Medical Center; 2013. [cited 2019 Dec 09]. Available from: http://digitalcommons.library.tmc.edu/utgsbs_dissertations/354.

Council of Science Editors:

Bartkowiak T. Novel Imaging-Based Techniques Reveal a Role for PD-1/PD-L1 in Tumor Immune Surveillance in the Lung. [Masters Thesis]. Texas Medical Center; 2013. Available from: http://digitalcommons.library.tmc.edu/utgsbs_dissertations/354


Louisiana State University

11. Dale, Renee. Mathematical Model of the Split Firefly Luciferase Assay.

Degree: MS, 2015, Louisiana State University

 The firefly luciferase complementation assay is widely used as a bioluminescent reporter technology to detect protein-protein interactions in vitro and in vivo. Firefly luciferase oxidates… (more)

Subjects/Keywords: firefly luciferase; complementation assay; bioluminesence; reporter assay; mathematical model

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Dale, R. (2015). Mathematical Model of the Split Firefly Luciferase Assay. (Masters Thesis). Louisiana State University. Retrieved from etd-07022015-161605 ; https://digitalcommons.lsu.edu/gradschool_theses/855

Chicago Manual of Style (16th Edition):

Dale, Renee. “Mathematical Model of the Split Firefly Luciferase Assay.” 2015. Masters Thesis, Louisiana State University. Accessed December 09, 2019. etd-07022015-161605 ; https://digitalcommons.lsu.edu/gradschool_theses/855.

MLA Handbook (7th Edition):

Dale, Renee. “Mathematical Model of the Split Firefly Luciferase Assay.” 2015. Web. 09 Dec 2019.

Vancouver:

Dale R. Mathematical Model of the Split Firefly Luciferase Assay. [Internet] [Masters thesis]. Louisiana State University; 2015. [cited 2019 Dec 09]. Available from: etd-07022015-161605 ; https://digitalcommons.lsu.edu/gradschool_theses/855.

Council of Science Editors:

Dale R. Mathematical Model of the Split Firefly Luciferase Assay. [Masters Thesis]. Louisiana State University; 2015. Available from: etd-07022015-161605 ; https://digitalcommons.lsu.edu/gradschool_theses/855


Texas Medical Center

12. Roh, Whijae; and#60;pand#62;0000-0002-7395-9939and#60;/pand#62. INTEGRATIVE CANCER IMMUNOGENOMIC ANALYSIS OF SERIAL MELANOMA BIOPSIES REVEALS CORRELATES OF RESPONSE AND RESISTANCE TO SEQUENTIAL CTLA-4 AND PD-1 BLOCKADE TREATMENT.

Degree: PhD, 2017, Texas Medical Center

  Melanoma is the most malignant form of skin cancer. The five-year survival rate for metastatic melanoma is 19.9%. Although targeted therapy of BRAF and… (more)

Subjects/Keywords: cancer immunology; immunotherapy; immune checkpoint blockade; CTLA-4; PD-1; genomics; melanoma; response; resistance; biomarker; Bioinformatics; Computational Biology; Genomics; Medical Immunology; Medicine and Health Sciences; Skin and Connective Tissue Diseases

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Roh, W. a. (2017). INTEGRATIVE CANCER IMMUNOGENOMIC ANALYSIS OF SERIAL MELANOMA BIOPSIES REVEALS CORRELATES OF RESPONSE AND RESISTANCE TO SEQUENTIAL CTLA-4 AND PD-1 BLOCKADE TREATMENT. (Doctoral Dissertation). Texas Medical Center. Retrieved from http://digitalcommons.library.tmc.edu/utgsbs_dissertations/813

Chicago Manual of Style (16th Edition):

Roh, Whijae; and#60;pand#62;0000-0002-7395-9939and#60;/pand#62. “INTEGRATIVE CANCER IMMUNOGENOMIC ANALYSIS OF SERIAL MELANOMA BIOPSIES REVEALS CORRELATES OF RESPONSE AND RESISTANCE TO SEQUENTIAL CTLA-4 AND PD-1 BLOCKADE TREATMENT.” 2017. Doctoral Dissertation, Texas Medical Center. Accessed December 09, 2019. http://digitalcommons.library.tmc.edu/utgsbs_dissertations/813.

MLA Handbook (7th Edition):

Roh, Whijae; and#60;pand#62;0000-0002-7395-9939and#60;/pand#62. “INTEGRATIVE CANCER IMMUNOGENOMIC ANALYSIS OF SERIAL MELANOMA BIOPSIES REVEALS CORRELATES OF RESPONSE AND RESISTANCE TO SEQUENTIAL CTLA-4 AND PD-1 BLOCKADE TREATMENT.” 2017. Web. 09 Dec 2019.

Vancouver:

Roh Wa. INTEGRATIVE CANCER IMMUNOGENOMIC ANALYSIS OF SERIAL MELANOMA BIOPSIES REVEALS CORRELATES OF RESPONSE AND RESISTANCE TO SEQUENTIAL CTLA-4 AND PD-1 BLOCKADE TREATMENT. [Internet] [Doctoral dissertation]. Texas Medical Center; 2017. [cited 2019 Dec 09]. Available from: http://digitalcommons.library.tmc.edu/utgsbs_dissertations/813.

Council of Science Editors:

Roh Wa. INTEGRATIVE CANCER IMMUNOGENOMIC ANALYSIS OF SERIAL MELANOMA BIOPSIES REVEALS CORRELATES OF RESPONSE AND RESISTANCE TO SEQUENTIAL CTLA-4 AND PD-1 BLOCKADE TREATMENT. [Doctoral Dissertation]. Texas Medical Center; 2017. Available from: http://digitalcommons.library.tmc.edu/utgsbs_dissertations/813


University of Melbourne

13. Hogg, Simon John. BET bromodomain inhibition as combined apoptotic and immunomodulatory therapy for the treatment of MYC-driven lymphoma.

Degree: 2017, University of Melbourne

 Bromodomain and Extra-Terminal (BET) proteins are a conserved family of ‘epigenetic readers’ that bind to acetylated lysine residues on histone and non-histone proteins to modulate… (more)

Subjects/Keywords: bromodomain; epigenetics; PD-L1; cancer

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Hogg, S. J. (2017). BET bromodomain inhibition as combined apoptotic and immunomodulatory therapy for the treatment of MYC-driven lymphoma. (Doctoral Dissertation). University of Melbourne. Retrieved from http://hdl.handle.net/11343/191790

Chicago Manual of Style (16th Edition):

Hogg, Simon John. “BET bromodomain inhibition as combined apoptotic and immunomodulatory therapy for the treatment of MYC-driven lymphoma.” 2017. Doctoral Dissertation, University of Melbourne. Accessed December 09, 2019. http://hdl.handle.net/11343/191790.

MLA Handbook (7th Edition):

Hogg, Simon John. “BET bromodomain inhibition as combined apoptotic and immunomodulatory therapy for the treatment of MYC-driven lymphoma.” 2017. Web. 09 Dec 2019.

Vancouver:

Hogg SJ. BET bromodomain inhibition as combined apoptotic and immunomodulatory therapy for the treatment of MYC-driven lymphoma. [Internet] [Doctoral dissertation]. University of Melbourne; 2017. [cited 2019 Dec 09]. Available from: http://hdl.handle.net/11343/191790.

Council of Science Editors:

Hogg SJ. BET bromodomain inhibition as combined apoptotic and immunomodulatory therapy for the treatment of MYC-driven lymphoma. [Doctoral Dissertation]. University of Melbourne; 2017. Available from: http://hdl.handle.net/11343/191790

14. Pinot Roussel, Hélène. Étude du microenvironnement immunitaire des tumeurs du poumon avec réarrangement ALK et rôle des lymphocytes résidents mémoires dans les tumeurs muqueuses (poumon, ORL) : Analyse of the tumor microenvironment of ALK rearranged adenocarcinoma and key role of the resident memory T cells in mucosal tumor.

Degree: Docteur es, Immunologie, 2016, Sorbonne Paris Cité

 Les cancers du poumon se placent au quatrième rang des cancers tous sexes confondus et constituent la première cause de mortalité par cancer pour l’homme… (more)

Subjects/Keywords: Cancer du poumon; ALK; PD-L1; Biomarqueurs; Tumeur muqueuse; Vaccin; Trm; Lung cancer; ALK; PD-L1; Biomarker; Mucosal tumor; Vaccin; Trm; 616.99424

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Pinot Roussel, H. (2016). Étude du microenvironnement immunitaire des tumeurs du poumon avec réarrangement ALK et rôle des lymphocytes résidents mémoires dans les tumeurs muqueuses (poumon, ORL) : Analyse of the tumor microenvironment of ALK rearranged adenocarcinoma and key role of the resident memory T cells in mucosal tumor. (Doctoral Dissertation). Sorbonne Paris Cité. Retrieved from http://www.theses.fr/2016USPCB086

Chicago Manual of Style (16th Edition):

Pinot Roussel, Hélène. “Étude du microenvironnement immunitaire des tumeurs du poumon avec réarrangement ALK et rôle des lymphocytes résidents mémoires dans les tumeurs muqueuses (poumon, ORL) : Analyse of the tumor microenvironment of ALK rearranged adenocarcinoma and key role of the resident memory T cells in mucosal tumor.” 2016. Doctoral Dissertation, Sorbonne Paris Cité. Accessed December 09, 2019. http://www.theses.fr/2016USPCB086.

MLA Handbook (7th Edition):

Pinot Roussel, Hélène. “Étude du microenvironnement immunitaire des tumeurs du poumon avec réarrangement ALK et rôle des lymphocytes résidents mémoires dans les tumeurs muqueuses (poumon, ORL) : Analyse of the tumor microenvironment of ALK rearranged adenocarcinoma and key role of the resident memory T cells in mucosal tumor.” 2016. Web. 09 Dec 2019.

Vancouver:

Pinot Roussel H. Étude du microenvironnement immunitaire des tumeurs du poumon avec réarrangement ALK et rôle des lymphocytes résidents mémoires dans les tumeurs muqueuses (poumon, ORL) : Analyse of the tumor microenvironment of ALK rearranged adenocarcinoma and key role of the resident memory T cells in mucosal tumor. [Internet] [Doctoral dissertation]. Sorbonne Paris Cité; 2016. [cited 2019 Dec 09]. Available from: http://www.theses.fr/2016USPCB086.

Council of Science Editors:

Pinot Roussel H. Étude du microenvironnement immunitaire des tumeurs du poumon avec réarrangement ALK et rôle des lymphocytes résidents mémoires dans les tumeurs muqueuses (poumon, ORL) : Analyse of the tumor microenvironment of ALK rearranged adenocarcinoma and key role of the resident memory T cells in mucosal tumor. [Doctoral Dissertation]. Sorbonne Paris Cité; 2016. Available from: http://www.theses.fr/2016USPCB086


University of Sydney

15. Lee, Aimei Yen-Jia. The glycoprotein Basigin in liver disease .

Degree: 2016, University of Sydney

 Basigin (Bsg) is a membrane glycoprotein expressed by many different cell types. Bsg is instrumental in tissue development, extracellular matrix (ECM) remodelling, and has been… (more)

Subjects/Keywords: liver; cancer; biomarker; glycosylation

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Lee, A. Y. (2016). The glycoprotein Basigin in liver disease . (Thesis). University of Sydney. Retrieved from http://hdl.handle.net/2123/17163

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Lee, Aimei Yen-Jia. “The glycoprotein Basigin in liver disease .” 2016. Thesis, University of Sydney. Accessed December 09, 2019. http://hdl.handle.net/2123/17163.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Lee, Aimei Yen-Jia. “The glycoprotein Basigin in liver disease .” 2016. Web. 09 Dec 2019.

Vancouver:

Lee AY. The glycoprotein Basigin in liver disease . [Internet] [Thesis]. University of Sydney; 2016. [cited 2019 Dec 09]. Available from: http://hdl.handle.net/2123/17163.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Lee AY. The glycoprotein Basigin in liver disease . [Thesis]. University of Sydney; 2016. Available from: http://hdl.handle.net/2123/17163

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


George Mason University

16. Hodge, K Alex. Protein Network Mapping of Bladder Cancer: An Analysis of Tumor Compartment and the Surrounding Microenvironment .

Degree: George Mason University

 The interaction between tumor and stroma has become of intense interest in the field of oncology in order to better understand the driving forces behind… (more)

Subjects/Keywords: cancer; bladder; arrays; immunotherapy; stroma; PD-L1

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Hodge, K. A. (n.d.). Protein Network Mapping of Bladder Cancer: An Analysis of Tumor Compartment and the Surrounding Microenvironment . (Thesis). George Mason University. Retrieved from http://hdl.handle.net/1920/10802

Note: this citation may be lacking information needed for this citation format:
No year of publication.
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Hodge, K Alex. “Protein Network Mapping of Bladder Cancer: An Analysis of Tumor Compartment and the Surrounding Microenvironment .” Thesis, George Mason University. Accessed December 09, 2019. http://hdl.handle.net/1920/10802.

Note: this citation may be lacking information needed for this citation format:
No year of publication.
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Hodge, K Alex. “Protein Network Mapping of Bladder Cancer: An Analysis of Tumor Compartment and the Surrounding Microenvironment .” Web. 09 Dec 2019.

Note: this citation may be lacking information needed for this citation format:
No year of publication.

Vancouver:

Hodge KA. Protein Network Mapping of Bladder Cancer: An Analysis of Tumor Compartment and the Surrounding Microenvironment . [Internet] [Thesis]. George Mason University; [cited 2019 Dec 09]. Available from: http://hdl.handle.net/1920/10802.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation
No year of publication.

Council of Science Editors:

Hodge KA. Protein Network Mapping of Bladder Cancer: An Analysis of Tumor Compartment and the Surrounding Microenvironment . [Thesis]. George Mason University; Available from: http://hdl.handle.net/1920/10802

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation
No year of publication.


University of Kentucky

17. El-Refai, Sherif M. EXPLORING THE EFFECT OF CHRONIC INFLAMMATION ON RESPONSE TO IMMUNE CHECKPOINT INHIBITORS IN CANCER.

Degree: 2018, University of Kentucky

 Precision medicine has allowed for the development of monoclonal antibodies that unmask the anti-tumor immune response. These agents have provided some patients durable clinical benefit.… (more)

Subjects/Keywords: Immune checkpoint inhibitors; biomarkers of response; health outcomes research; cancer; PD-1/PD-L1; Pharmacy and Pharmaceutical Sciences

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

El-Refai, S. M. (2018). EXPLORING THE EFFECT OF CHRONIC INFLAMMATION ON RESPONSE TO IMMUNE CHECKPOINT INHIBITORS IN CANCER. (Doctoral Dissertation). University of Kentucky. Retrieved from https://uknowledge.uky.edu/pharmacy_etds/82

Chicago Manual of Style (16th Edition):

El-Refai, Sherif M. “EXPLORING THE EFFECT OF CHRONIC INFLAMMATION ON RESPONSE TO IMMUNE CHECKPOINT INHIBITORS IN CANCER.” 2018. Doctoral Dissertation, University of Kentucky. Accessed December 09, 2019. https://uknowledge.uky.edu/pharmacy_etds/82.

MLA Handbook (7th Edition):

El-Refai, Sherif M. “EXPLORING THE EFFECT OF CHRONIC INFLAMMATION ON RESPONSE TO IMMUNE CHECKPOINT INHIBITORS IN CANCER.” 2018. Web. 09 Dec 2019.

Vancouver:

El-Refai SM. EXPLORING THE EFFECT OF CHRONIC INFLAMMATION ON RESPONSE TO IMMUNE CHECKPOINT INHIBITORS IN CANCER. [Internet] [Doctoral dissertation]. University of Kentucky; 2018. [cited 2019 Dec 09]. Available from: https://uknowledge.uky.edu/pharmacy_etds/82.

Council of Science Editors:

El-Refai SM. EXPLORING THE EFFECT OF CHRONIC INFLAMMATION ON RESPONSE TO IMMUNE CHECKPOINT INHIBITORS IN CANCER. [Doctoral Dissertation]. University of Kentucky; 2018. Available from: https://uknowledge.uky.edu/pharmacy_etds/82


University of Lund

18. Berntsson, Jonna. The immune microenvironment of colorectal cancer - Relationship with survival, sidedness, and pre-diagnostic anthropometry.

Degree: 2019, University of Lund

 Colorectal cancer (CRC) is the third most common cancer worldwide. Increasing evidence suggests that CRC should be considered a heterogeneous disease, with multiple differences between… (more)

Subjects/Keywords: Medical and Health Sciences; Colorectal Cancer; T cells; B cells; PD-1; PD-L1; immune system; prognosis; anthropometry; obesity

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Berntsson, J. (2019). The immune microenvironment of colorectal cancer - Relationship with survival, sidedness, and pre-diagnostic anthropometry. (Doctoral Dissertation). University of Lund. Retrieved from http://lup.lub.lu.se/record/aa4c19a6-2fb7-47da-b43f-c7058934e5e3 ; https://portal.research.lu.se/ws/files/69673841/Jonna_Berntsson.pdf

Chicago Manual of Style (16th Edition):

Berntsson, Jonna. “The immune microenvironment of colorectal cancer - Relationship with survival, sidedness, and pre-diagnostic anthropometry.” 2019. Doctoral Dissertation, University of Lund. Accessed December 09, 2019. http://lup.lub.lu.se/record/aa4c19a6-2fb7-47da-b43f-c7058934e5e3 ; https://portal.research.lu.se/ws/files/69673841/Jonna_Berntsson.pdf.

MLA Handbook (7th Edition):

Berntsson, Jonna. “The immune microenvironment of colorectal cancer - Relationship with survival, sidedness, and pre-diagnostic anthropometry.” 2019. Web. 09 Dec 2019.

Vancouver:

Berntsson J. The immune microenvironment of colorectal cancer - Relationship with survival, sidedness, and pre-diagnostic anthropometry. [Internet] [Doctoral dissertation]. University of Lund; 2019. [cited 2019 Dec 09]. Available from: http://lup.lub.lu.se/record/aa4c19a6-2fb7-47da-b43f-c7058934e5e3 ; https://portal.research.lu.se/ws/files/69673841/Jonna_Berntsson.pdf.

Council of Science Editors:

Berntsson J. The immune microenvironment of colorectal cancer - Relationship with survival, sidedness, and pre-diagnostic anthropometry. [Doctoral Dissertation]. University of Lund; 2019. Available from: http://lup.lub.lu.se/record/aa4c19a6-2fb7-47da-b43f-c7058934e5e3 ; https://portal.research.lu.se/ws/files/69673841/Jonna_Berntsson.pdf

19. 脇田, 晃行. REG Iα Promotes PD-L1 Expression in Esophageal Cancer Cells. : 食道扁平上皮癌細胞において REG Iαは PD-L1 の発現を誘導する.

Degree: 博士(医学), 2017, Akita University / 秋田大学

 Regenerating gene (REG)Iα is known to contribute to carcinogenesis and to be associated with a poor prognosis in various cancers. Programmed death-1 ligand(PD-L1) is a… (more)

Subjects/Keywords: PD-L1; REG Iα; esophageal cancer

Page 1 Page 2

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

脇田, . (2017). REG Iα Promotes PD-L1 Expression in Esophageal Cancer Cells. : 食道扁平上皮癌細胞において REG Iαは PD-L1 の発現を誘導する. (Thesis). Akita University / 秋田大学. Retrieved from http://hdl.handle.net/10295/2884

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

脇田, 晃行. “REG Iα Promotes PD-L1 Expression in Esophageal Cancer Cells. : 食道扁平上皮癌細胞において REG Iαは PD-L1 の発現を誘導する.” 2017. Thesis, Akita University / 秋田大学. Accessed December 09, 2019. http://hdl.handle.net/10295/2884.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

脇田, 晃行. “REG Iα Promotes PD-L1 Expression in Esophageal Cancer Cells. : 食道扁平上皮癌細胞において REG Iαは PD-L1 の発現を誘導する.” 2017. Web. 09 Dec 2019.

Vancouver:

脇田 . REG Iα Promotes PD-L1 Expression in Esophageal Cancer Cells. : 食道扁平上皮癌細胞において REG Iαは PD-L1 の発現を誘導する. [Internet] [Thesis]. Akita University / 秋田大学; 2017. [cited 2019 Dec 09]. Available from: http://hdl.handle.net/10295/2884.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

脇田 . REG Iα Promotes PD-L1 Expression in Esophageal Cancer Cells. : 食道扁平上皮癌細胞において REG Iαは PD-L1 の発現を誘導する. [Thesis]. Akita University / 秋田大学; 2017. Available from: http://hdl.handle.net/10295/2884

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of Helsinki

20. Jokinen, Nora. Assay optimization and screening for hepatitis C virus replication inhibitors from marine-derived substances.

Degree: Farmaceutiska fakulteten, 2013, University of Helsinki

 Maailmassa on arviolta 180 miljoonaa hepatiitti C -viruksen kantajaa. C-hepatiitti aiheuttaa usein oireettomia maksasairauksia. Krooniset infektiot voivat aiheuttaa maksakirroosia, johtaa elinsiirtoon tai maksasyöpään. Lääkkeiden kehitys… (more)

Subjects/Keywords: Hepatitis C virus; replication inhibitor; antiviral screening; cell-based assay; luciferase reporter; Farmakognosi; Pharmacognosy; Farmakognosia

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Jokinen, N. (2013). Assay optimization and screening for hepatitis C virus replication inhibitors from marine-derived substances. (Masters Thesis). University of Helsinki. Retrieved from http://hdl.handle.net/10138/40773

Chicago Manual of Style (16th Edition):

Jokinen, Nora. “Assay optimization and screening for hepatitis C virus replication inhibitors from marine-derived substances.” 2013. Masters Thesis, University of Helsinki. Accessed December 09, 2019. http://hdl.handle.net/10138/40773.

MLA Handbook (7th Edition):

Jokinen, Nora. “Assay optimization and screening for hepatitis C virus replication inhibitors from marine-derived substances.” 2013. Web. 09 Dec 2019.

Vancouver:

Jokinen N. Assay optimization and screening for hepatitis C virus replication inhibitors from marine-derived substances. [Internet] [Masters thesis]. University of Helsinki; 2013. [cited 2019 Dec 09]. Available from: http://hdl.handle.net/10138/40773.

Council of Science Editors:

Jokinen N. Assay optimization and screening for hepatitis C virus replication inhibitors from marine-derived substances. [Masters Thesis]. University of Helsinki; 2013. Available from: http://hdl.handle.net/10138/40773


Uppsala University

21. Handin, Niklas. Identification of new regulatory mechanisms that determine coagulation FXI plasma concentration.

Degree: Biology Education Centre, 2015, Uppsala University

  FXI is a protein in the coagulation cascade in humans proven to be involved in the propagation and stabilization of developing thrombi in previous… (more)

Subjects/Keywords: FXI; F11; blood plasma; coagulation; GWAS; Meta-analysis; pathway analysis; eQTL; miRNA; luciferase reporter assay

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Handin, N. (2015). Identification of new regulatory mechanisms that determine coagulation FXI plasma concentration. (Thesis). Uppsala University. Retrieved from http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-261267

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Handin, Niklas. “Identification of new regulatory mechanisms that determine coagulation FXI plasma concentration.” 2015. Thesis, Uppsala University. Accessed December 09, 2019. http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-261267.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Handin, Niklas. “Identification of new regulatory mechanisms that determine coagulation FXI plasma concentration.” 2015. Web. 09 Dec 2019.

Vancouver:

Handin N. Identification of new regulatory mechanisms that determine coagulation FXI plasma concentration. [Internet] [Thesis]. Uppsala University; 2015. [cited 2019 Dec 09]. Available from: http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-261267.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Handin N. Identification of new regulatory mechanisms that determine coagulation FXI plasma concentration. [Thesis]. Uppsala University; 2015. Available from: http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-261267

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


UCLA

22. Zaretsky, Jesse Meir. Identification of Features of Response and Resistance to Anti-Programmed-Death-1 Immunotherapy in Melanoma.

Degree: Molecular and Medical Pharmacology, 2017, UCLA

 Checkpoint blockade immunotherapy takes advantage of an endogenous anti-cancer immune response and promotes tumor killing by altering the balance of signals that control T-cell activity.… (more)

Subjects/Keywords: Oncology; Immunology; Immunotherapy; Melanoma; PD-1; Resistance

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Zaretsky, J. M. (2017). Identification of Features of Response and Resistance to Anti-Programmed-Death-1 Immunotherapy in Melanoma. (Thesis). UCLA. Retrieved from http://www.escholarship.org/uc/item/9838m5rq

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Zaretsky, Jesse Meir. “Identification of Features of Response and Resistance to Anti-Programmed-Death-1 Immunotherapy in Melanoma.” 2017. Thesis, UCLA. Accessed December 09, 2019. http://www.escholarship.org/uc/item/9838m5rq.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Zaretsky, Jesse Meir. “Identification of Features of Response and Resistance to Anti-Programmed-Death-1 Immunotherapy in Melanoma.” 2017. Web. 09 Dec 2019.

Vancouver:

Zaretsky JM. Identification of Features of Response and Resistance to Anti-Programmed-Death-1 Immunotherapy in Melanoma. [Internet] [Thesis]. UCLA; 2017. [cited 2019 Dec 09]. Available from: http://www.escholarship.org/uc/item/9838m5rq.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Zaretsky JM. Identification of Features of Response and Resistance to Anti-Programmed-Death-1 Immunotherapy in Melanoma. [Thesis]. UCLA; 2017. Available from: http://www.escholarship.org/uc/item/9838m5rq

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


Université Paris-Sud – Paris XI

23. Desbois, Melanie. Étude d’un nouvel agent immuno-modulateur sushi-IL-15Rα/IL-15, le RLI : évaluation de son potentiel thérapeutique dans le traitement des cancers : Study of a New Immunomodulator sushi-IL-15Rα/IL-15, RLI : Evaluation of its therapeutic potential in cancer.

Degree: Docteur es, Oncologie - Immunologie, 2014, Université Paris-Sud – Paris XI

Chez les patients, la tumeur développe une immunosuppression qui compromet les capacités des effecteurs de l’immunité à réagir. Longtemps décriée, l’immunothérapie est considérée aujourd’hui comme… (more)

Subjects/Keywords: Immunothérapie; Interleukine-15; IL-15R; Trans-présentation; Cellules NK; Lymphocytes T CD8; PD-1; Cancer; Microenvironnement; Immunotherapy; IL-15; Transpresentation; NK cells; CD8 T cells; PD-1; Cancer; Microenvironment

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Desbois, M. (2014). Étude d’un nouvel agent immuno-modulateur sushi-IL-15Rα/IL-15, le RLI : évaluation de son potentiel thérapeutique dans le traitement des cancers : Study of a New Immunomodulator sushi-IL-15Rα/IL-15, RLI : Evaluation of its therapeutic potential in cancer. (Doctoral Dissertation). Université Paris-Sud – Paris XI. Retrieved from http://www.theses.fr/2014PA11T030

Chicago Manual of Style (16th Edition):

Desbois, Melanie. “Étude d’un nouvel agent immuno-modulateur sushi-IL-15Rα/IL-15, le RLI : évaluation de son potentiel thérapeutique dans le traitement des cancers : Study of a New Immunomodulator sushi-IL-15Rα/IL-15, RLI : Evaluation of its therapeutic potential in cancer.” 2014. Doctoral Dissertation, Université Paris-Sud – Paris XI. Accessed December 09, 2019. http://www.theses.fr/2014PA11T030.

MLA Handbook (7th Edition):

Desbois, Melanie. “Étude d’un nouvel agent immuno-modulateur sushi-IL-15Rα/IL-15, le RLI : évaluation de son potentiel thérapeutique dans le traitement des cancers : Study of a New Immunomodulator sushi-IL-15Rα/IL-15, RLI : Evaluation of its therapeutic potential in cancer.” 2014. Web. 09 Dec 2019.

Vancouver:

Desbois M. Étude d’un nouvel agent immuno-modulateur sushi-IL-15Rα/IL-15, le RLI : évaluation de son potentiel thérapeutique dans le traitement des cancers : Study of a New Immunomodulator sushi-IL-15Rα/IL-15, RLI : Evaluation of its therapeutic potential in cancer. [Internet] [Doctoral dissertation]. Université Paris-Sud – Paris XI; 2014. [cited 2019 Dec 09]. Available from: http://www.theses.fr/2014PA11T030.

Council of Science Editors:

Desbois M. Étude d’un nouvel agent immuno-modulateur sushi-IL-15Rα/IL-15, le RLI : évaluation de son potentiel thérapeutique dans le traitement des cancers : Study of a New Immunomodulator sushi-IL-15Rα/IL-15, RLI : Evaluation of its therapeutic potential in cancer. [Doctoral Dissertation]. Université Paris-Sud – Paris XI; 2014. Available from: http://www.theses.fr/2014PA11T030


Case Western Reserve University

24. Dorand, Rodney Dixon, Jr. DEFINING THE ROLE OF IMMUNE THERAPY IN PEDIATRIC CNS MALIGNANCY.

Degree: PhD, Pathology, 2016, Case Western Reserve University

 Understanding the mechanisms tumors employ to escape detection by both the innate and adaptive immune systems is imperative for developing new immune based therapeutics. Available… (more)

Subjects/Keywords: Biology; Immunology; Nanotechnology; Neurobiology; Medulloblatsoma, Cancer Immunotherapy, Viral Nanoparticles, Immune Checkpoint, PD-L1, Cyclin Dependent Kinase-5, Organotypic Brain Slice Culture, Microglia, CX3CR1, IRF2BP2

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Dorand, Rodney Dixon, J. (2016). DEFINING THE ROLE OF IMMUNE THERAPY IN PEDIATRIC CNS MALIGNANCY. (Doctoral Dissertation). Case Western Reserve University. Retrieved from http://rave.ohiolink.edu/etdc/view?acc_num=case1465566883

Chicago Manual of Style (16th Edition):

Dorand, Rodney Dixon, Jr. “DEFINING THE ROLE OF IMMUNE THERAPY IN PEDIATRIC CNS MALIGNANCY.” 2016. Doctoral Dissertation, Case Western Reserve University. Accessed December 09, 2019. http://rave.ohiolink.edu/etdc/view?acc_num=case1465566883.

MLA Handbook (7th Edition):

Dorand, Rodney Dixon, Jr. “DEFINING THE ROLE OF IMMUNE THERAPY IN PEDIATRIC CNS MALIGNANCY.” 2016. Web. 09 Dec 2019.

Vancouver:

Dorand, Rodney Dixon J. DEFINING THE ROLE OF IMMUNE THERAPY IN PEDIATRIC CNS MALIGNANCY. [Internet] [Doctoral dissertation]. Case Western Reserve University; 2016. [cited 2019 Dec 09]. Available from: http://rave.ohiolink.edu/etdc/view?acc_num=case1465566883.

Council of Science Editors:

Dorand, Rodney Dixon J. DEFINING THE ROLE OF IMMUNE THERAPY IN PEDIATRIC CNS MALIGNANCY. [Doctoral Dissertation]. Case Western Reserve University; 2016. Available from: http://rave.ohiolink.edu/etdc/view?acc_num=case1465566883


Texas Medical Center

25. Jaiswal, Ashvin; and#60;pand#62;https://orcid.org/0000-0002-5550-5589and#60;/pand#62. TUMOR IMMUNOTHERAPY: MECHANISMS OF ACQUIRED RESISTANCE AND CHARACTERIZATION OF IMMUNE RELATED TOXICITIES.

Degree: PhD, 2018, Texas Medical Center

  Tumor immunotherapy has shown very promising clinical benefit across an array of cancers; however, two major challenges remain unresolved in the field. First, many… (more)

Subjects/Keywords: Immunotherapy Resistance; Immunooncology; CTLA-4; PD-1; PD-L1; 4-1BB; Immune Related Adverse Effects (IRAEs); Immunometabolism; Checkpoint Blockade Immunotherapy; Hepatotoxicity; Genetic Processes; Immunity; Immunology and Infectious Disease; Immunopathology; Immunoprophylaxis and Therapy; Medical Biochemistry; Medical Biotechnology; Medical Genetics; Medical Immunology; Medicine and Health Sciences

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Jaiswal, A. a. o. (2018). TUMOR IMMUNOTHERAPY: MECHANISMS OF ACQUIRED RESISTANCE AND CHARACTERIZATION OF IMMUNE RELATED TOXICITIES. (Doctoral Dissertation). Texas Medical Center. Retrieved from http://digitalcommons.library.tmc.edu/utgsbs_dissertations/832

Chicago Manual of Style (16th Edition):

Jaiswal, Ashvin; and#60;pand#62;https://orcid org/0000-0002-5550-5589and#60;/pand#62. “TUMOR IMMUNOTHERAPY: MECHANISMS OF ACQUIRED RESISTANCE AND CHARACTERIZATION OF IMMUNE RELATED TOXICITIES.” 2018. Doctoral Dissertation, Texas Medical Center. Accessed December 09, 2019. http://digitalcommons.library.tmc.edu/utgsbs_dissertations/832.

MLA Handbook (7th Edition):

Jaiswal, Ashvin; and#60;pand#62;https://orcid org/0000-0002-5550-5589and#60;/pand#62. “TUMOR IMMUNOTHERAPY: MECHANISMS OF ACQUIRED RESISTANCE AND CHARACTERIZATION OF IMMUNE RELATED TOXICITIES.” 2018. Web. 09 Dec 2019.

Vancouver:

Jaiswal Aao. TUMOR IMMUNOTHERAPY: MECHANISMS OF ACQUIRED RESISTANCE AND CHARACTERIZATION OF IMMUNE RELATED TOXICITIES. [Internet] [Doctoral dissertation]. Texas Medical Center; 2018. [cited 2019 Dec 09]. Available from: http://digitalcommons.library.tmc.edu/utgsbs_dissertations/832.

Council of Science Editors:

Jaiswal Aao. TUMOR IMMUNOTHERAPY: MECHANISMS OF ACQUIRED RESISTANCE AND CHARACTERIZATION OF IMMUNE RELATED TOXICITIES. [Doctoral Dissertation]. Texas Medical Center; 2018. Available from: http://digitalcommons.library.tmc.edu/utgsbs_dissertations/832


Kyoto University

26. Mulati, Kumuluzi. VISTA expressed in tumor cells regulates T cell function .

Degree: 2019, Kyoto University

Subjects/Keywords: VISTA; immune checkpoint; cancer immunotherapy; B7-H5; PD-1

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Mulati, K. (2019). VISTA expressed in tumor cells regulates T cell function . (Thesis). Kyoto University. Retrieved from http://hdl.handle.net/2433/242370

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Mulati, Kumuluzi. “VISTA expressed in tumor cells regulates T cell function .” 2019. Thesis, Kyoto University. Accessed December 09, 2019. http://hdl.handle.net/2433/242370.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Mulati, Kumuluzi. “VISTA expressed in tumor cells regulates T cell function .” 2019. Web. 09 Dec 2019.

Vancouver:

Mulati K. VISTA expressed in tumor cells regulates T cell function . [Internet] [Thesis]. Kyoto University; 2019. [cited 2019 Dec 09]. Available from: http://hdl.handle.net/2433/242370.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Mulati K. VISTA expressed in tumor cells regulates T cell function . [Thesis]. Kyoto University; 2019. Available from: http://hdl.handle.net/2433/242370

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

27. Inoue, Yusuke. Clinical significance of PD-L1 and PD-L2 copy number gains in non-small-cell lung cancer : 非小細胞肺がんにおけるPD-L1、PD-L2遺伝子コピー数増加の臨床的意義.

Degree: 博士(医学), 2017, Hamamatsu University School of Medicine / 浜松医科大学

New reliable biomarkers are needed to predict the response to immune checkpoint inhibitors against programmed death‑1 (PD‑1) and its ligand (PD‑L1), because PD‑L1 expression on… (more)

Subjects/Keywords: PD‑L1; PD‑L2; amplification; copy number; non‑small‑cell lung cancer

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Inoue, Y. (2017). Clinical significance of PD-L1 and PD-L2 copy number gains in non-small-cell lung cancer : 非小細胞肺がんにおけるPD-L1、PD-L2遺伝子コピー数増加の臨床的意義. (Thesis). Hamamatsu University School of Medicine / 浜松医科大学. Retrieved from http://hdl.handle.net/10271/3219

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Inoue, Yusuke. “Clinical significance of PD-L1 and PD-L2 copy number gains in non-small-cell lung cancer : 非小細胞肺がんにおけるPD-L1、PD-L2遺伝子コピー数増加の臨床的意義.” 2017. Thesis, Hamamatsu University School of Medicine / 浜松医科大学. Accessed December 09, 2019. http://hdl.handle.net/10271/3219.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Inoue, Yusuke. “Clinical significance of PD-L1 and PD-L2 copy number gains in non-small-cell lung cancer : 非小細胞肺がんにおけるPD-L1、PD-L2遺伝子コピー数増加の臨床的意義.” 2017. Web. 09 Dec 2019.

Vancouver:

Inoue Y. Clinical significance of PD-L1 and PD-L2 copy number gains in non-small-cell lung cancer : 非小細胞肺がんにおけるPD-L1、PD-L2遺伝子コピー数増加の臨床的意義. [Internet] [Thesis]. Hamamatsu University School of Medicine / 浜松医科大学; 2017. [cited 2019 Dec 09]. Available from: http://hdl.handle.net/10271/3219.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Inoue Y. Clinical significance of PD-L1 and PD-L2 copy number gains in non-small-cell lung cancer : 非小細胞肺がんにおけるPD-L1、PD-L2遺伝子コピー数増加の臨床的意義. [Thesis]. Hamamatsu University School of Medicine / 浜松医科大学; 2017. Available from: http://hdl.handle.net/10271/3219

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of Toronto

28. Lee, Minji. Investigating Molecular Differences related to T-bet-Positive Tumor-infiltrating Lymphocytes in Axillary Node-negative Breast Cancer.

Degree: 2017, University of Toronto

The clinical outcomes of axillary node-negative (ANN) breast cancer (BC) patients were previously shown to be positively associated with T-bet+ tumor-infiltrating lymphocytes (TILs). This study… (more)

Subjects/Keywords: BRD4; Breast Cancer; miRNA; PD-L1; T-bet; TIL; 0307

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Lee, M. (2017). Investigating Molecular Differences related to T-bet-Positive Tumor-infiltrating Lymphocytes in Axillary Node-negative Breast Cancer. (Masters Thesis). University of Toronto. Retrieved from http://hdl.handle.net/1807/77837

Chicago Manual of Style (16th Edition):

Lee, Minji. “Investigating Molecular Differences related to T-bet-Positive Tumor-infiltrating Lymphocytes in Axillary Node-negative Breast Cancer.” 2017. Masters Thesis, University of Toronto. Accessed December 09, 2019. http://hdl.handle.net/1807/77837.

MLA Handbook (7th Edition):

Lee, Minji. “Investigating Molecular Differences related to T-bet-Positive Tumor-infiltrating Lymphocytes in Axillary Node-negative Breast Cancer.” 2017. Web. 09 Dec 2019.

Vancouver:

Lee M. Investigating Molecular Differences related to T-bet-Positive Tumor-infiltrating Lymphocytes in Axillary Node-negative Breast Cancer. [Internet] [Masters thesis]. University of Toronto; 2017. [cited 2019 Dec 09]. Available from: http://hdl.handle.net/1807/77837.

Council of Science Editors:

Lee M. Investigating Molecular Differences related to T-bet-Positive Tumor-infiltrating Lymphocytes in Axillary Node-negative Breast Cancer. [Masters Thesis]. University of Toronto; 2017. Available from: http://hdl.handle.net/1807/77837


Harvard University

29. Mengwasser, Kristen Elizabeth. Genetic Screening Approaches to Cancer Driver Characterization and Synthetic Lethal Target Discovery.

Degree: PhD, 2018, Harvard University

Advances in genetic screening technology have expanded the toolkit for systematic perturbation of gene function. While the CRISPR-Cas9 system robustly probes genetic loss-of-function in mammalian… (more)

Subjects/Keywords: Genetic Screening Technologies; CRISPR-Cas9; BRCA2; PD-L1; Cancer Driver Genes

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Mengwasser, K. E. (2018). Genetic Screening Approaches to Cancer Driver Characterization and Synthetic Lethal Target Discovery. (Doctoral Dissertation). Harvard University. Retrieved from http://nrs.harvard.edu/urn-3:HUL.InstRepos:41121232

Chicago Manual of Style (16th Edition):

Mengwasser, Kristen Elizabeth. “Genetic Screening Approaches to Cancer Driver Characterization and Synthetic Lethal Target Discovery.” 2018. Doctoral Dissertation, Harvard University. Accessed December 09, 2019. http://nrs.harvard.edu/urn-3:HUL.InstRepos:41121232.

MLA Handbook (7th Edition):

Mengwasser, Kristen Elizabeth. “Genetic Screening Approaches to Cancer Driver Characterization and Synthetic Lethal Target Discovery.” 2018. Web. 09 Dec 2019.

Vancouver:

Mengwasser KE. Genetic Screening Approaches to Cancer Driver Characterization and Synthetic Lethal Target Discovery. [Internet] [Doctoral dissertation]. Harvard University; 2018. [cited 2019 Dec 09]. Available from: http://nrs.harvard.edu/urn-3:HUL.InstRepos:41121232.

Council of Science Editors:

Mengwasser KE. Genetic Screening Approaches to Cancer Driver Characterization and Synthetic Lethal Target Discovery. [Doctoral Dissertation]. Harvard University; 2018. Available from: http://nrs.harvard.edu/urn-3:HUL.InstRepos:41121232


University of Sydney

30. Kakavand, Hojabr. Targeted therapies and immune checkpoint inhibitors in the treatment of metastatic melanoma patients .

Degree: 2017, University of Sydney

 The previously dismal prospects of patients with advanced stage metastatic melanoma have greatly improved in recent years. Enhanced understanding of both the pathogenesis of melanoma… (more)

Subjects/Keywords: Melanoma; Targeted therapies; Immunotherapy; BRAF; MEK; PD-1

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Kakavand, H. (2017). Targeted therapies and immune checkpoint inhibitors in the treatment of metastatic melanoma patients . (Thesis). University of Sydney. Retrieved from http://hdl.handle.net/2123/17184

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Kakavand, Hojabr. “Targeted therapies and immune checkpoint inhibitors in the treatment of metastatic melanoma patients .” 2017. Thesis, University of Sydney. Accessed December 09, 2019. http://hdl.handle.net/2123/17184.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Kakavand, Hojabr. “Targeted therapies and immune checkpoint inhibitors in the treatment of metastatic melanoma patients .” 2017. Web. 09 Dec 2019.

Vancouver:

Kakavand H. Targeted therapies and immune checkpoint inhibitors in the treatment of metastatic melanoma patients . [Internet] [Thesis]. University of Sydney; 2017. [cited 2019 Dec 09]. Available from: http://hdl.handle.net/2123/17184.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Kakavand H. Targeted therapies and immune checkpoint inhibitors in the treatment of metastatic melanoma patients . [Thesis]. University of Sydney; 2017. Available from: http://hdl.handle.net/2123/17184

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

[1] [2] [3] [4] [5] … [2093]

.